Chinese Pharma Giant to Construct $2b br Plant
Humanwell Healthcare, China’s biggest pharmaceutical manufacturing company, has invested two billion Birr for the construction of its plant in Ethiopia – its second investment destination on the continent, after Mali, in West Africa.
Mebratu Melese (PhD), state minister for Industry, accompanied Xurong Li, the company’s operation management department’s deputy head, as well as zonal and wereda level officials, two weeks before laying the building’s cornerstone.
The factory is to be constructed in the Hageremaraim Kesem district of Amhara, located approximately 65Km north of Addis Abeba at.
“When the plant is completed, the prices of medicine for locals will be low,” said Mebrahtu.
Tablets, capsules, injections and syrups are four of the pharmaceutical items that the factory will produce.
The plant is scheduled to be finalized and go fully operational with the next two years.
The local pharmaceutical industry comprises 22 pharmaceutical and medical suppliers and manufacturers, with nine directly involved in the manufacture of pharmaceutical products.